MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 195 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q2 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,076,000 | -92.3% | 30,517 | -90.8% | 0.02% | -91.5% |
| Q4 2021 | $13,888,000 | -27.9% | 331,463 | -15.5% | 0.20% | -36.6% |
| Q3 2021 | $19,257,000 | +1.9% | 392,361 | -13.4% | 0.31% | -10.8% |
| Q2 2021 | $18,901,000 | +3.2% | 452,944 | -11.9% | 0.35% | -13.3% |
| Q1 2021 | $18,317,000 | +5.5% | 513,957 | -17.0% | 0.41% | -11.9% |
| Q4 2020 | $17,369,000 | – | 619,217 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $764,690,000 | 24.22% |
| Nekton Capital Ltd. | 1,111,102 | $39,189,000 | 9.66% |
| Pavadi Capital LLC | 133,279 | $4,701,000 | 4.14% |
| Curi Wealth Management, LLC | 420,446 | $14,829,000 | 2.57% |
| Select Equity Group, L.P. | 19,100,056 | $673,659,000 | 2.18% |
| Ownership Capital B.V. | 4,205,521 | $148,329,000 | 1.96% |
| Beck Bode, LLC | 167,969 | $5,924,000 | 1.34% |
| Parkman Healthcare Partners LLC | 77,389 | $2,730,000 | 0.80% |
| STONE RUN CAPITAL, LLC | 55,285 | $1,960,000 | 0.72% |
| Champlain Investment Partners, LLC | 3,582,530 | $126,356,000 | 0.65% |